BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1349301)

  • 1. Management of the non-descended testis: doubtful value of luteinizing-hormone-releasing-hormone (LHRH). A double-blind, placebo-controlled multicentre study.
    Olsen LH; Genster HG; Mosegaard A; Jørgensen FS; Hofman N; Jensen VB; Lassen LB; Rassmussen M; Vinzents L; Dammegaard L
    Int J Androl; 1992 Apr; 15(2):135-43. PubMed ID: 1349301
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Double-blind, placebo-controlled study of luteinising-hormone-releasing-hormone nasal spray in treatment of undescended testes.
    deMuinck Keizer-Schrama SM; Hazebroek FW; Matroos AW; Drop SL; Molenaar JC; Visser HK
    Lancet; 1986 Apr; 1(8486):876-80. PubMed ID: 2870353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Undescended testis treated by intranasal application of luteinizing hormone-releasing hormone (LH-RH)].
    Rasmussen TB; Kristensen ES; Gandrup P; Ingerslev HJ
    Ugeskr Laeger; 1991 Feb; 153(9):640-3. PubMed ID: 1672569
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Why luteinizing-hormone-releasing-hormone nasal spray will not replace orchiopexy in the treatment of boys with undescended testes.
    Hazebroek FW; de Muinck Keizer-Schrama SM; van Maarschalkerweerd M; Visser HK; Molenaar JC
    J Pediatr Surg; 1987 Dec; 22(12):1177-82. PubMed ID: 3326926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of LHRH treatment on testicular descent and hormonal response in cryptorchidism.
    Wit JM; Delemarre-Van de Waal HA; Bax NM; Van den Brande JL
    Clin Endocrinol (Oxf); 1986 May; 24(5):539-48. PubMed ID: 2878745
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of luteinizing-hormone-releasing hormone nasal spray in the treatment of cryptorchidism: is there still an indication? A clinical study in 78 boys with 103 undescended testicles.
    Witjes JA; de Vries JD; Lock MT; Debruyne FM
    Eur Urol; 1990; 17(3):226-8. PubMed ID: 1972065
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review and meta-analysis of comparative studies assessing the efficacy of luteinizing hormone-releasing hormone therapy for children with cryptorchidism.
    Li T; Gao L; Chen P; Bu S; Cao D; Yang L; Wei Q
    Int Urol Nephrol; 2016 May; 48(5):635-44. PubMed ID: 26898822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of cryptorchidism by intranasal synthetic luteinising-hormone releasing hormone. Results of a collaborative double-blind study.
    Illig R; Exner GU; Kollmann F; Kellerer K; Borkenstein M; Lunglmayr L; Kuber W; Prader A
    Lancet; 1977 Sep; 2(8037):518-20. PubMed ID: 95729
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Effects of gonadoliberin administered nasally in cryptorchidism in aged 1 to 6].
    Job JC; Joab N; Safar A; Canlorbe P
    Arch Fr Pediatr; 1987 Feb; 44(2):91-5. PubMed ID: 2883952
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LHRH and cryptorchidism.
    Frick J
    Eur J Pediatr; 1993; 152 Suppl 2():S28-30. PubMed ID: 8101808
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LHRH treatment in unilateral cryptorchidism: effect on testicular descent and hormonal response.
    Karpe B; Eneroth P; Ritzén EM
    J Pediatr; 1983 Dec; 103(6):892-7. PubMed ID: 6139422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A review and meta-analysis of hormonal treatment of cryptorchidism.
    Pyörälä S; Huttunen NP; Uhari M
    J Clin Endocrinol Metab; 1995 Sep; 80(9):2795-9. PubMed ID: 7673426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined therapy with LHRH and HCG in cryptorchid infants.
    Lala R; Matarazzo P; Chiabotto P; de Sanctis C; Canavese F; Hadziselimovic F
    Eur J Pediatr; 1993; 152 Suppl 2():S31-3. PubMed ID: 8101810
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hormonal treatment of cryptorchidism.
    de Muinck Keizer-Schrama SM
    Horm Res; 1988; 30(4-5):178-86. PubMed ID: 2907895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hormonal therapy of cryptorchidism. A randomized, double-blind study comparing human chorionic gonadotropin and gonadotropin-releasing hormone.
    Rajfer J; Handelsman DJ; Swerdloff RS; Hurwitz R; Kaplan H; Vandergast T; Ehrlich RM
    N Engl J Med; 1986 Feb; 314(8):466-70. PubMed ID: 2868413
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of cryptorchidism with human chorionic gonadotropin or gonadotropin releasing hormone. A double-blind controlled study of 243 boys.
    Christiansen P; Müller J; Buhl S; Hansen OR; Hobolth N; Jacobsen BB; Jørgensen PH; Kastrup KW; Nielsen K; Nielsen LB
    Horm Res; 1988; 30(4-5):187-92. PubMed ID: 2907896
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Luteinising hormone releasing hormone for incomplete descent of the testis.
    Klidjian AM; Swift PG; Johnstone JM
    Arch Dis Child; 1985 Jun; 60(6):568-71. PubMed ID: 2861791
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LH-RH nasal spray treatment for cryptorchidism. A double-blind, placebo-controlled study.
    De Muinck Keizer-Schrama SM; Hazebroek FW; Drop SL; Molenaar JC; Visser HK
    Eur J Pediatr; 1987; 146 Suppl 2():S35-7. PubMed ID: 2891518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Buserelin treatment of cryptorchidism: a randomized, double-blind, placebo-controlled study.
    Bica DT; Hadziselimovic F
    J Urol; 1992 Aug; 148(2 Pt 2):617-21. PubMed ID: 1353540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose every-second-day LHRH treatment following bilateral orchidopexy in children with bilateral cryptorchidism may improve their fertility outcome.
    Bogaert G; Vanhoyland M; Hadziselimovic F
    J Pediatr Urol; 2023 Feb; 19(1):128.e1-128.e7. PubMed ID: 36336621
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.